| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |